NCT05986877View on ClinicalTrials.gov

A Study of STSA-1201 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

March 14, 2024

Study Completion Date

March 14, 2024

Conditions
Healthy
Interventions
DRUG

STSA-1201 Subcutaneous injection

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Trial Locations (1)

102600

Beijing Shijitan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Staidson (Beijing) Biopharmaceuticals Co., Ltd

INDUSTRY

NCT05986877 - A Study of STSA-1201 in Healthy Subjects | Biotech Hunter | Biotech Hunter